Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för David Zaccardelli. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att David Zaccardelli har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) | President and CEO, Director | 12 176 144 |
US:DOVA / Dova Pharmaceuticals, Inc. | President & CEO, Director | 0 |
US:MLNT / Melinta Therapeutics, Inc. | Director | 30 000 |
US:UTHR / United Therapeutics Corporation | EVP & Chief Operating Officer | 25 000 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av David Zaccardelli. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i VRNA / Verona Pharma plc - Depositary Receipt (Common Stock). Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i VRNA / Verona Pharma plc - Depositary Receipt (Common Stock). Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av David Zaccardelli som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-09-03 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
G - Gift | −1 200 000 | 12 176 144 | −8,97 | ||||
2025-08-05 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −208 912 | 13 376 144 | −1,54 | 13,14 | −2 745 877 | 175 812 024 |
2025-08-05 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
M - Exercise | 255 696 | 13 585 056 | 1,92 | ||||
2025-07-09 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
F - Taxes | −90 320 | 13 329 360 | −0,67 | 11,44 | −1 033 378 | 152 505 207 | |
2025-07-09 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
M - Exercise | 229 512 | 13 419 680 | 1,74 | ||||
2025-06-13 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −400 000 | 13 190 168 | −2,94 | 11,40 | −4 560 520 | 150 385 062 |
2025-05-29 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −208 696 | 13 590 168 | −1,51 | 9,33 | −1 947 593 | 126 826 166 |
2025-05-29 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −157 704 | 13 798 864 | −1,13 | 9,30 | −1 466 805 | 128 343 234 |
2025-05-29 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −33 600 | 13 956 568 | −0,24 | 9,53 | −320 181 | 132 994 928 |
2025-05-05 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −400 000 | 13 990 168 | −2,78 | 9,09 | −3 637 520 | 127 223 790 |
2025-05-05 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −78 736 | 14 390 168 | −0,54 | 8,95 | −704 703 | 128 794 882 |
2025-05-05 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
M - Exercise | 200 000 | 14 468 904 | 1,40 | ||||
2025-05-05 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −108 272 | 14 268 904 | −0,75 | 8,95 | −969 056 | 127 709 545 |
2025-05-01 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −90 360 | 14 377 176 | −0,62 | 8,98 | −811 433 | 129 107 040 |
2025-05-01 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
M - Exercise | 229 512 | 14 467 536 | 1,61 | ||||
2025-02-04 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
F - Taxes | −166 728 | 14 238 024 | −1,16 | 7,16 | −1 194 189 | 101 979 847 | |
2025-02-04 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
A - Award | 200 000 | 14 404 752 | 1,41 | ||||
2024-12-06 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −162 800 | 14 204 752 | −1,13 | 5,01 | −815 400 | 71 145 921 |
2024-12-06 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −640 264 | 14 367 552 | −4,27 | 5,01 | −3 205 226 | 71 925 402 |
2024-12-06 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −67 608 | 15 007 816 | −0,45 | 5,00 | −338 162 | 75 066 094 |
2024-12-02 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −3 200 | 15 075 424 | −0,02 | 5,00 | −16 000 | 75 377 120 |
2024-12-02 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −98 888 | 15 078 624 | −0,65 | 5,01 | −495 033 | 75 483 592 |
2024-12-02 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −23 240 | 15 177 512 | −0,15 | 5,00 | −116 200 | 75 887 560 |
2024-11-26 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −1 600 | 15 200 752 | −0,01 | 5,00 | −8 000 | 76 003 760 |
2024-11-13 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −2 400 | 15 202 352 | −0,02 | 5,00 | −12 000 | 76 011 760 |
2024-11-05 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −94 144 | 15 204 752 | −0,62 | 4,39 | −413 462 | 66 776 230 |
2024-11-05 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −46 888 | 15 298 896 | −0,31 | 4,38 | −205 196 | 66 952 559 |
2024-11-01 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
F - Taxes | −245 952 | 15 345 784 | −1,58 | 4,24 | −1 043 132 | 65 084 539 | |
2024-11-01 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
A - Award | 200 000 | 15 591 736 | 1,30 | ||||
2024-11-01 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
A - Award | 800 000 | 15 391 736 | 5,48 | ||||
2024-10-25 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −4 800 | 14 591 736 | −0,03 | 4,38 | −21 004 | 63 850 518 |
2024-10-25 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −140 000 | 14 596 536 | −0,95 | 4,38 | −612 822 | 63 893 417 |
2024-10-25 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −16 | 14 736 536 | 0,00 | 4,38 | −70 | 64 472 345 |
2024-10-22 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −157 912 | 14 736 552 | −1,06 | 4,39 | −692 728 | 64 646 306 |
2024-10-22 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −110 456 | 14 894 464 | −0,74 | 4,38 | −483 753 | 65 231 795 |
2024-10-22 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −245 784 | 15 004 920 | −1,61 | 4,38 | −1 076 755 | 65 735 054 |
2024-09-13 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −600 000 | 15 250 704 | −3,79 | 3,76 | −2 254 320 | 57 299 945 |
2024-08-14 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −8 216 | 15 850 704 | −0,05 | 3,25 | −26 702 | 51 514 788 |
2024-08-14 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −390 184 | 15 858 920 | −2,40 | 3,20 | −1 248 979 | 50 764 403 |
2024-08-14 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −1 600 | 16 249 104 | −0,01 | 3,13 | −5 008 | 50 859 696 |
2024-08-09 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
F - Taxes | −314 800 | 16 250 704 | −1,90 | 2,62 | −824 776 | 42 576 844 | |
2024-08-09 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
A - Award | 800 000 | 16 565 504 | 5,07 | ||||
2024-08-05 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
F - Taxes | −88 544 | 15 765 504 | −0,56 | 2,83 | −250 801 | 44 655 790 | |
2024-05-03 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
F - Taxes | −88 544 | 15 854 048 | −0,56 | 1,93 | −171 005 | 30 618 923 | |
2024-02-05 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
F - Taxes | −480 200 | 15 942 592 | −2,92 | 2,29 | −1 101 483 | 36 569 118 | |
2023-11-03 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
F - Taxes | −809 008 | 16 422 792 | −4,69 | 1,74 | −1 410 748 | 28 638 065 | |
2023-10-24 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
A - Award | 800 000 | 17 231 800 | 4,87 | ||||
2023-08-07 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −8 616 | 16 431 800 | −0,05 | 2,47 | −21 263 | 40 552 039 |
2023-08-07 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −150 000 | 16 440 416 | −0,90 | 2,50 | −374 880 | 41 087 888 |
2023-08-07 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −117 272 | 16 590 416 | −0,70 | 2,54 | −297 754 | 42 123 066 |
2023-08-03 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −73 704 | 16 707 688 | −0,44 | 2,59 | −191 114 | 43 323 035 |
2023-08-03 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −105 944 | 16 781 392 | −0,63 | 2,68 | −283 824 | 44 957 349 |
2023-05-03 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −455 536 | 16 887 336 | −2,63 | 2,58 | −1 173 415 | 43 500 089 |
2023-02-03 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −432 928 | 17 342 872 | −2,44 | 2,56 | −1 107 083 | 44 349 192 |
2022-12-21 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −600 000 | 17 775 800 | −3,27 | 2,12 | −1 269 600 | 37 613 593 |
2022-11-03 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −32 904 | 18 375 800 | −0,18 | 1,67 | −55 035 | 30 735 363 |
2022-11-03 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
F - Taxes | −454 856 | 18 408 704 | −2,41 | 1,60 | −727 770 | 29 453 926 | |
2022-09-28 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
A - Award | 3 600 000 | 18 863 560 | 23,59 | ||||
2022-08-11 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −600 000 | 15 263 560 | −3,78 | 1,75 | −1 050 000 | 26 711 230 |
2022-08-03 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −32 904 | 15 863 560 | −0,21 | 0,70 | −23 026 | 11 101 319 |
2022-08-03 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
F - Taxes | −454 864 | 15 896 464 | −2,78 | 0,67 | −305 896 | 10 690 372 | |
2022-05-05 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −32 904 | 16 351 328 | −0,20 | 0,50 | −16 307 | 8 103 718 |
2022-05-03 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
F - Taxes | −454 864 | 16 384 232 | −2,70 | 0,52 | −237 666 | 8 560 761 | |
2022-02-03 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −52 056 | 16 839 096 | −0,31 | 0,73 | −37 772 | 12 218 448 |
2022-02-03 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
F - Taxes | −288 648 | 16 891 152 | −1,68 | 0,78 | −224 077 | 13 112 601 | |
2022-02-03 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
A - Award | 334 448 | 17 179 800 | 1,99 | 0,75 | 250 000 | 12 841 900 | |
2021-11-03 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −52 056 | 16 845 352 | −0,31 | 0,64 | −33 373 | 10 799 555 |
2021-11-03 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
F - Taxes | −454 848 | 16 897 408 | −2,62 | 0,64 | −291 103 | 10 814 341 | |
2021-08-09 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −17 656 | 17 352 256 | −0,10 | 0,75 | −13 284 | 13 055 837 |
2021-08-04 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −18 400 | 17 369 912 | −0,11 | 0,74 | −13 675 | 12 909 319 |
2021-08-04 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −16 000 | 17 388 312 | −0,09 | 0,76 | −12 210 | 13 269 021 |
2021-08-04 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
F - Taxes | −454 848 | 17 404 312 | −2,55 | 0,78 | −357 056 | 13 662 385 | |
2021-05-05 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −52 056 | 17 859 160 | −0,29 | 0,81 | −41 926 | 14 383 767 |
2021-05-05 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
F - Taxes | −2 139 632 | 17 911 216 | −10,67 | 0,89 | −1 898 923 | 15 896 204 | |
2021-03-03 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
S - Sale | X | −43 392 | 20 050 848 | −0,22 | 1,14 | −49 627 | 22 932 155 |
2021-02-01 |
|
4 | VRNA |
Verona Pharma plc
Ordinary Shares |
A - Award | 529 104 | 20 094 240 | 2,70 | ||||
2021-01-04 | 3 | VRNA |
Verona Pharma plc
Ordinary Shares |
19 565 136 | ||||||||
2019-11-12 |
|
4 | DOVA |
Dova Pharmaceuticals Inc.
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | −1 000 000 | 0 | −100,00 | ||||
2019-11-12 |
|
4 | DOVA |
Dova Pharmaceuticals Inc.
Common Stock |
D - Sale to Issuer | −76 647 | 0 | −100,00 | ||||
2019-10-02 |
|
4 | DOVA |
Dova Pharmaceuticals Inc.
Common Stock |
S - Sale | X | −5 275 | 76 647 | −6,44 | 27,90 | −147 172 | 2 138 451 |
2019-07-03 |
|
4 | DOVA |
Dova Pharmaceuticals Inc.
Common Stock |
S - Sale | X | −4 551 | 81 922 | −5,26 | 16,22 | −73 817 | 1 328 775 |
2019-07-03 |
|
4 | DOVA |
Dova Pharmaceuticals Inc.
Common Stock |
S - Sale | X | −5 899 | 86 473 | −6,39 | 15,73 | −92 791 | 1 360 220 |
2019-06-12 |
|
4 | MLNT |
MELINTA THERAPEUTICS, INC. /NEW/
Melinta Restricted Stock Units |
A - Award | 30 000 | 30 000 | |||||
2018-12-21 |
|
4 | DOVA |
Dova Pharmaceuticals Inc.
Common Stock |
P - Purchase | 10 000 | 92 372 | 12,14 | 6,07 | 60 700 | 560 698 | |
2018-12-21 |
|
4 | DOVA |
Dova Pharmaceuticals Inc.
Employee Stock Option (right to buy) |
A - Award | 1 000 000 | 1 000 000 | |||||
2018-12-21 |
|
4 | DOVA |
Dova Pharmaceuticals Inc.
Common Stock |
A - Award | 82 372 | 82 372 | |||||
2018-06-14 |
|
4 | MLNT |
MELINTA THERAPEUTICS, INC. /NEW/
Stock Option (right to buy) |
A - Award | 9 100 | 9 100 | |||||
2018-06-14 |
|
4 | MLNT |
MELINTA THERAPEUTICS, INC. /NEW/
Stock Option (right to buy) |
A - Award | 25 000 | 25 000 | |||||
2018-05-31 |
|
4 | MLNT |
MELINTA THERAPEUTICS, INC. /NEW/
Common Stock |
P - Purchase | 40 000 | 46 500 | 615,38 | 5,00 | 200 000 | 232 500 | |
2016-12-13 |
|
4 | CEMP |
CEMPRA, INC.
Stock Option (Right to Buy) |
A - Award | 150 000 | 150 000 | |||||
2016-12-13 |
|
4 | CEMP |
CEMPRA, INC.
Restricted Stock Units |
A - Award | 50 000 | 50 000 | |||||
2016-08-12 |
|
4 | CEMP |
CEMPRA, INC.
Stock Option (Right to Buy) |
A - Award | 25 000 | 25 000 | |||||
2016-05-16 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −25 000 | 25 000 | −50,00 | |||
2016-05-16 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −64 000 | 0 | −100,00 | |||
2016-05-16 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −11 500 | 11 500 | −50,00 | |||
2016-05-16 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −10 750 | 0 | −100,00 | |||
2016-05-16 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −25 000 | 1 542 | −94,19 | 111,48 | −2 787 000 | 171 902 |
2016-05-16 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −64 000 | 26 542 | −70,69 | 111,48 | −7 134 720 | 2 958 902 |
2016-05-16 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −11 500 | 90 542 | −11,27 | 111,48 | −1 282 020 | 10 093 622 |
2016-05-16 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −10 750 | 102 042 | −9,53 | 111,48 | −1 198 410 | 11 375 642 |
2016-05-16 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 25 000 | 112 792 | 28,48 | 94,96 | 2 374 000 | 10 710 728 |
2016-05-16 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 64 000 | 87 792 | 269,00 | 65,80 | 4 211 200 | 5 776 714 |
2016-05-16 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 11 500 | 23 792 | 93,56 | 61,06 | 702 190 | 1 452 740 |
2016-05-16 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 10 750 | 12 292 | 697,15 | 47,50 | 510 625 | 583 870 |
2016-03-15 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Stock Options |
A - Award | 73 500 | 73 500 | |||||
2015-12-30 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −2 000 | 64 000 | −3,03 | |||
2015-12-30 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −2 000 | 1 375 | −59,26 | 159,23 | −318 460 | 218 941 |
2015-12-30 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 2 000 | 3 375 | 145,45 | 65,80 | 131 600 | 222 075 |
2015-12-23 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −2 000 | 66 000 | −2,94 | |||
2015-12-23 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −2 000 | 1 375 | −59,26 | 157,93 | −315 860 | 217 154 |
2015-12-23 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 2 000 | 3 375 | 145,45 | 65,80 | 131 600 | 222 075 |
2015-12-16 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | −2 000 | 68 000 | −2,86 | ||||
2015-12-16 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −2 000 | 1 375 | −59,26 | 159,97 | −319 940 | 219 959 | |
2015-12-16 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 2 000 | 3 375 | 145,45 | 65,80 | 131 600 | 222 075 | |
2015-12-10 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −2 000 | 70 000 | −2,78 | |||
2015-12-10 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −2 000 | 1 375 | −59,26 | 160,30 | −320 600 | 220 412 |
2015-12-10 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 2 000 | 3 375 | 145,45 | 65,80 | 131 600 | 222 075 |
2015-12-02 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −2 000 | 72 000 | −2,70 | |||
2015-12-02 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −2 000 | 1 375 | −59,26 | 159,00 | −318 000 | 218 625 |
2015-12-02 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 2 000 | 3 375 | 145,45 | 65,80 | 131 600 | 222 075 |
2015-11-25 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −1 000 | 74 000 | −1,33 | |||
2015-11-25 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −1 000 | 74 000 | −1,33 | |||
2015-11-25 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −1 000 | 1 375 | −42,11 | 154,23 | −154 230 | 212 066 |
2015-11-25 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −1 000 | 1 375 | −42,11 | 154,23 | −154 230 | 212 066 |
2015-11-25 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 1 000 | 2 375 | 72,73 | 65,80 | 65 800 | 156 275 |
2015-11-25 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 1 000 | 2 375 | 72,73 | 61,06 | 61 060 | 145 018 |
2015-11-18 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | −1 000 | 24 000 | −4,00 | ||||
2015-11-18 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −1 000 | 1 375 | −42,11 | 148,02 | −148 020 | 203 528 | |
2015-11-18 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 1 000 | 2 375 | 72,73 | 61,06 | 61 060 | 145 018 | |
2015-11-12 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −2 000 | 25 000 | −7,41 | |||
2015-11-12 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −2 000 | 1 375 | −59,26 | 156,75 | −313 500 | 215 531 |
2015-11-12 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 2 000 | 3 375 | 145,45 | 61,06 | 122 120 | 206 078 |
2015-11-04 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | −2 000 | 27 000 | −6,90 | ||||
2015-11-04 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −2 000 | 1 375 | −59,26 | 152,60 | −305 200 | 209 825 | |
2015-11-04 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 2 000 | 3 375 | 145,45 | 61,06 | 122 120 | 206 078 | |
2015-10-28 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −3 000 | 29 000 | −9,38 | |||
2015-10-28 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −3 000 | 1 375 | −68,57 | 137,10 | −411 300 | 188 512 |
2015-10-28 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 3 000 | 4 375 | 218,18 | 61,06 | 183 180 | 267 138 |
2015-10-07 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −1 000 | 32 000 | −3,03 | |||
2015-10-07 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −1 000 | 1 375 | −42,11 | 125,28 | −125 280 | 172 260 |
2015-10-07 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 1 000 | 2 375 | 72,73 | 61,06 | 61 060 | 145 018 |
2015-09-30 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −1 000 | 33 000 | −2,94 | |||
2015-09-30 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −1 000 | 1 375 | −42,11 | 136,97 | −136 970 | 188 334 |
2015-09-30 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 1 000 | 2 375 | 72,73 | 61,06 | 61 060 | 145 018 |
2015-09-23 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −1 000 | 34 000 | −2,86 | |||
2015-09-23 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −1 000 | 1 375 | −42,11 | 144,82 | −144 820 | 199 128 |
2015-09-23 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 1 000 | 2 375 | 72,73 | 61,06 | 61 060 | 145 018 |
2015-09-17 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −2 000 | 35 000 | −5,41 | |||
2015-09-17 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −2 000 | 1 375 | −59,26 | 154,91 | −309 820 | 213 001 |
2015-09-17 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 2 000 | 3 375 | 145,45 | 61,06 | 122 120 | 206 078 |
2015-09-09 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −2 000 | 37 000 | −5,13 | |||
2015-09-09 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −2 000 | 1 375 | −59,26 | 154,12 | −308 240 | 211 915 |
2015-09-09 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 2 000 | 3 375 | 145,45 | 61,06 | 122 120 | 206 078 |
2015-09-02 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −1 000 | 39 000 | −2,50 | |||
2015-09-02 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −1 000 | 1 375 | −42,11 | 144,61 | −144 610 | 198 839 |
2015-09-02 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 1 000 | 2 375 | 72,73 | 61,06 | 61 060 | 145 018 |
2015-08-26 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −2 000 | 40 000 | −4,76 | |||
2015-08-26 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −2 000 | 1 375 | −59,26 | 152,68 | −305 360 | 209 935 |
2015-08-26 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 2 000 | 3 375 | 145,45 | 61,06 | 122 120 | 206 078 |
2015-08-18 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −2 000 | 42 000 | −4,55 | |||
2015-08-18 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −2 000 | 1 375 | −59,26 | 167,58 | −335 160 | 230 422 |
2015-08-18 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 2 000 | 3 375 | 145,45 | 61,06 | 122 120 | 206 078 |
2015-08-13 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −2 000 | 44 000 | −4,35 | |||
2015-08-13 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −2 000 | 1 375 | −59,26 | 165,16 | −330 320 | 227 095 |
2015-08-13 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 2 000 | 3 375 | 145,45 | 61,06 | 122 120 | 206 078 |
2015-07-21 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −928 | 0 | −100,00 | |||
2015-07-21 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −928 | 1 375 | −40,30 | 175,17 | −162 558 | 240 859 |
2015-07-21 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 928 | 2 303 | 67,49 | 57,15 | 53 035 | 131 616 |
2015-07-14 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −4 000 | 928 | −81,17 | |||
2015-07-14 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −4 000 | 1 375 | −74,42 | 175,05 | −700 200 | 240 694 |
2015-07-14 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 4 000 | 5 375 | 290,91 | 57,15 | 228 600 | 307 181 |
2015-07-08 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −2 000 | 4 928 | −28,87 | |||
2015-07-08 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −2 000 | 1 375 | −59,26 | 170,76 | −341 520 | 234 795 |
2015-07-08 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 2 000 | 3 375 | 145,45 | 57,15 | 114 300 | 192 881 |
2015-07-01 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −2 000 | 6 928 | −22,40 | |||
2015-07-01 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −2 000 | 1 375 | −59,26 | 173,95 | −347 900 | 239 181 |
2015-07-01 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 2 000 | 3 375 | 145,45 | 57,15 | 114 300 | 192 881 |
2015-06-23 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −4 000 | 8 928 | −30,94 | |||
2015-06-23 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −4 000 | 1 375 | −74,42 | 185,89 | −743 560 | 255 599 |
2015-06-23 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 4 000 | 5 375 | 290,91 | 57,15 | 228 600 | 307 181 |
2015-06-16 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −4 000 | 12 928 | −23,63 | |||
2015-06-16 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −4 000 | 1 375 | −74,42 | 186,90 | −747 600 | 256 988 |
2015-06-16 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 4 000 | 5 375 | 290,91 | 57,15 | 228 600 | 307 181 |
2015-06-10 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −4 000 | 16 928 | −19,11 | |||
2015-06-10 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −4 000 | 1 375 | −74,42 | 178,12 | −712 480 | 244 915 |
2015-06-10 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 4 000 | 5 375 | 290,91 | 57,15 | 228 600 | 307 181 |
2015-06-02 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −4 000 | 20 928 | −16,05 | |||
2015-06-02 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −4 000 | 1 375 | −74,42 | 181,92 | −727 680 | 250 140 |
2015-06-02 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 4 000 | 5 375 | 290,91 | 57,15 | 228 600 | 307 181 |
2015-05-26 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −4 000 | 24 928 | −13,83 | |||
2015-05-26 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | X | −4 000 | 1 375 | −74,42 | 182,50 | −730 000 | 250 938 |
2015-05-26 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 4 000 | 5 375 | 290,91 | 57,15 | 228 600 | 307 181 |
2015-05-19 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | −4 000 | 28 928 | −12,15 | ||||
2015-05-19 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
D - Sale to Issuer | −4 000 | 1 375 | −74,42 | 178,06 | −712 240 | 244 832 | |
2015-05-19 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | 4 000 | 5 375 | 290,91 | 57,15 | 228 600 | 307 181 | |
2015-04-14 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −3 250 | 0 | −100,00 | |||
2015-04-14 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | X | −3 250 | 1 153 | −73,81 | 185,82 | −603 915 | 214 250 |
2015-04-14 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 3 250 | 4 403 | 281,87 | 51,37 | 166 952 | 226 182 |
2015-04-10 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −4 000 | 3 250 | −55,17 | |||
2015-04-10 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | X | −4 000 | 1 153 | −77,62 | 184,84 | −739 360 | 213 121 |
2015-04-10 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 4 000 | 5 153 | 346,92 | 51,37 | 205 480 | 264 710 |
2015-04-08 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −4 000 | 7 250 | −35,56 | |||
2015-04-08 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | X | −4 000 | 1 153 | −77,62 | 179,34 | −717 360 | 206 779 |
2015-04-08 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 4 000 | 5 153 | 346,92 | 51,37 | 205 480 | 264 710 |
2015-04-03 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −4 000 | 11 250 | −26,23 | |||
2015-04-03 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | X | −4 000 | 1 153 | −77,62 | 174,73 | −698 920 | 201 464 |
2015-04-03 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 4 000 | 5 153 | 346,92 | 51,37 | 205 480 | 264 710 |
2015-04-02 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −4 000 | 15 250 | −20,78 | |||
2015-04-02 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | X | −4 000 | 1 153 | −77,62 | 172,44 | −689 740 | 198 818 |
2015-04-02 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 4 000 | 5 153 | 346,92 | 51,37 | 205 480 | 264 710 |
2015-03-26 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −4 000 | 19 250 | −17,20 | |||
2015-03-26 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | X | −4 000 | 1 153 | −77,62 | 167,52 | −670 080 | 193 151 |
2015-03-26 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 4 000 | 5 153 | 346,92 | 51,37 | 205 480 | 264 710 |
2015-03-24 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −2 750 | 10 750 | −20,37 | |||
2015-03-24 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −1 750 | 23 250 | −7,00 | |||
2015-03-24 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | X | −2 750 | 1 153 | −70,46 | 179,51 | −493 652 | 206 975 |
2015-03-24 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 2 750 | 3 903 | 238,51 | 47,50 | 130 625 | 185 392 |
2015-03-24 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | X | −1 750 | 1 153 | −60,28 | 179,51 | −314 142 | 206 975 |
2015-03-24 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 1 750 | 2 903 | 151,78 | 51,37 | 89 898 | 149 127 |
2015-03-24 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −4 000 | 13 500 | −22,86 | |||
2015-03-24 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | X | −4 000 | 1 153 | −77,62 | 175,82 | −703 280 | 202 720 |
2015-03-24 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 4 000 | 5 153 | 346,92 | 47,50 | 190 000 | 244 768 |
2015-03-18 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −4 000 | 17 500 | −18,60 | |||
2015-03-18 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | X | −4 000 | 1 153 | −77,62 | 177,34 | −709 360 | 204 473 |
2015-03-18 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 4 000 | 5 153 | 346,92 | 47,50 | 190 000 | 244 768 |
2015-03-16 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
A - Award | 46 500 | 46 500 | |||||
2015-03-13 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
A - Award | 37 500 | 37 500 | |||||
2015-02-24 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −1 458 | 0 | −100,00 | |||
2015-02-24 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | X | −1 458 | 1 153 | −55,84 | 155,16 | −226 223 | 178 899 |
2015-02-24 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 1 458 | 2 611 | 126,45 | 50,09 | 73 031 | 130 785 |
2015-02-18 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −4 000 | 1 458 | −73,29 | |||
2015-02-18 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | X | −4 000 | 1 153 | −77,62 | 155,14 | −620 560 | 178 876 |
2015-02-18 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 4 000 | 5 153 | 346,92 | 50,09 | 200 360 | 258 114 |
2015-02-11 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −4 000 | 5 458 | −42,29 | |||
2015-02-11 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | X | −4 000 | 1 153 | −77,62 | 146,68 | −586 720 | 169 122 |
2015-02-11 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 4 000 | 5 153 | 346,92 | 50,09 | 200 360 | 258 114 |
2015-02-04 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −4 000 | 9 458 | −29,72 | |||
2015-02-04 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | X | −4 000 | 1 153 | −77,62 | 141,99 | −567 960 | 163 714 |
2015-02-04 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 4 000 | 5 153 | 346,92 | 50,09 | 200 360 | 258 114 |
2015-01-28 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −4 000 | 13 458 | −22,91 | |||
2015-01-28 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | X | −4 000 | 1 153 | −77,62 | 147,19 | −588 760 | 169 710 |
2015-01-28 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 4 000 | 5 153 | 346,92 | 50,09 | 200 360 | 258 114 |
2015-01-22 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −4 000 | 17 458 | −18,64 | |||
2015-01-22 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | X | −4 000 | 1 153 | −77,62 | 146,48 | −585 920 | 168 891 |
2015-01-22 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 4 000 | 5 153 | 346,92 | 50,09 | 200 360 | 258 114 |
2015-01-14 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −3 000 | 21 458 | −12,27 | |||
2015-01-14 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | X | −3 000 | 1 153 | −72,24 | 134,71 | −404 130 | 155 321 |
2015-01-14 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 3 000 | 4 153 | 260,19 | 50,09 | 150 270 | 208 024 |
2015-01-07 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −500 | 21 500 | −2,27 | |||
2015-01-07 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Share Tracking Award |
M - Exercise | X | −2 500 | 24 458 | −9,27 | |||
2015-01-07 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | X | −500 | 1 153 | −30,25 | 124,93 | −62 465 | 144 044 |
2015-01-07 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 500 | 1 653 | 43,37 | 47,50 | 23 750 | 78 518 |
2015-01-07 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
S - Sale | X | −2 500 | 1 153 | −68,44 | 124,93 | −312 325 | 144 044 |
2015-01-07 |
|
4 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
M - Exercise | X | 2 500 | 3 653 | 216,83 | 50,09 | 125 225 | 182 979 |
2015-01-02 | 3 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
2 306 | ||||||||
2015-01-02 | 3 | UTHR |
UNITED THERAPEUTICS Corp
Common Stock |
2 306 |